Retaining Analysts Views in Focus: Symantec Corporation (NASDAQ:SYMC), VMware, Inc. (NYSE:VMW)

Symantec Corporation (NASDAQ:SYMC) [Trend Analysis] knocking active thrust in leading trading session, shares a loss of -0.58% to 24.11 with around 3.64 Million shares have changed hands in this session.

Symantec Corp. (SYMC) revealed the findings of a decade-long research campaign that helped unearth an international cybercriminal gang dubbed “Bayrob.” Symantec’s wealth of intelligence led to a successful FBI sting operation and the capture of three criminals in Romania. The group is responsible for stealing up to $35 million USD from victims through auto auction scams, credit card fraud and computer intrusion.

Lets us look over what analysts have to say about performance of the SYMC. Starting with EPS for the final quarter of this year. EPS is usually the indicator of profitability for the company. According to WSJ analysis, the Q4 2016 current estimates trends were for $0.28 as compared to the next year Q1 current trend of $0.30. While on annual basis the current EPS estimates trend for FY 2017 came in for $1.73 as compared to three months ago $1.72.

The stock prices target chart showed high target of 31.00 kept by analysts at WSJ while the average price target was for 26.05 as compared to current price of 24.11. Somehow, the stock managed to gain BUY ratings by 11 analysts in current tenure, 15 recommend as HOLD, 1 stands at Underweight. Overall, the consensus ratings were for Overweight by the pool of analysts.

The stock is going forward its fifty-two week low with 66.58% and lagging behind from its 52-week high price with -5.96%. Similar, the positive performance for the quarter recorded as -3.01% and for the year was 49.43%, while the YTD performance remained at 46.09%. SYMC has Average True Range for 14 days of 0.52.

Shares of VMware, Inc. (NYSE:VMW) [Trend Analysis] swings enthusiastically in regular trading session, it a decrease of -2.89% to close at $79.54. Finally to see some strong financial remarks by WSJ over VMW performance. Out of the pool of analysts 14 gave their BUY ratings on the stock in previous month as 14 analysts having BUY in current month. The stock was ranked as Underweight by 1 analyst. Majority ranked Overweight from the pool of analysts.

The next year first quarter EPS estimates trend for current period shows $1.40 while one month ago this estimate trend was for $1.40. EPS indicator shows the robustness of the stock and its analysis opens up the clear picture of company’s profitability. On annual basis of EPS, FY 2017 Estimate Trends at current were for $4.70 and for the one month was for $4.70 as compared to three months ago was for $4.59. Whereas, VMW received highest price target of 95.00 and low target of 68.00. The stock price target chart showed average price target of 82.74 as compared to current price of 79.54.

Moving forward to saw long-term intention, the experts calculate Return on Investment of 10.40%. The stock is going forward its fifty-two week low with 83.91% and lagging behind from its 52-week high price with -4.17%. VMW last month stock price volatility remained 1.95%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *